BIOMAT Database Logo BIOMAT Database Logo

A Patient with Dilated Cardiomyopathy and Portal Hypertension: Which Beta-Blocker to Use? 2017

Rathindranath Sarkar, and Rudrajit Paul, and Debaditya Roy, and Asim Saha, and Tanmay Jyoti Sau, and Jayati Mondal
Professor and HOD.

UI MeSH Term Description Entries
D006975 Hypertension, Portal Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN. Cruveilhier-Baumgarten Disease,Cruveilhier-Baumgarten Syndrome,Cruveilhier Baumgarten Disease,Cruveilhier Baumgarten Syndrome,Disease, Cruveilhier-Baumgarten,Portal Hypertension,Portal Hypertensions,Syndrome, Cruveilhier-Baumgarten
D008297 Male Males
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D002227 Carbazoles Benzo-indoles similar to CARBOLINES which are pyrido-indoles. In plants, carbazoles are derived from indole and form some of the INDOLE ALKALOIDS.
D002311 Cardiomyopathy, Dilated A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein. Cardiomyopathy, Congestive,Congestive Cardiomyopathy,Dilated Cardiomyopathy,Cardiomyopathy, Dilated, 1a,Cardiomyopathy, Dilated, Autosomal Recessive,Cardiomyopathy, Dilated, CMD1A,Cardiomyopathy, Dilated, LMNA,Cardiomyopathy, Dilated, With Conduction Defect 1,Cardiomyopathy, Dilated, with Conduction Deffect1,Cardiomyopathy, Familial Idiopathic,Cardiomyopathy, Idiopathic Dilated,Cardiomyopathies, Congestive,Cardiomyopathies, Dilated,Cardiomyopathies, Familial Idiopathic,Cardiomyopathies, Idiopathic Dilated,Congestive Cardiomyopathies,Dilated Cardiomyopathies,Dilated Cardiomyopathies, Idiopathic,Dilated Cardiomyopathy, Idiopathic,Familial Idiopathic Cardiomyopathies,Familial Idiopathic Cardiomyopathy,Idiopathic Cardiomyopathies, Familial,Idiopathic Cardiomyopathy, Familial,Idiopathic Dilated Cardiomyopathies,Idiopathic Dilated Cardiomyopathy
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000066491 Clinical Decision-Making Process of formulating a diagnosis based on medical history and physical or mental examinations, and/or choosing an appropriate intervention. Medical Decision-Making,Clinical Decision Making,Decision-Making, Clinical,Decision-Making, Medical,Medical Decision Making
D000077261 Carvedilol A carbazole and propanol derivative that acts as a non-cardioselective beta blocker and vasodilator. It has blocking activity for ALPHA 1 ADRENERGIC RECEPTORS and, at higher doses, may function as a blocker of CALCIUM CHANNELS; it also has antioxidant properties. Carvedilol is used in the treatment of HYPERTENSION; ANGINA PECTORIS; and HEART FAILURE. It can also reduce the risk of death following MYOCARDIAL INFARCTION. BM 14190,BM-14190,Carvedilol Hydrochloride,Carvedilol, (+),Carvedilol, (+)-isomer,Carvedilol, (+-)-isomer,Carvedilol, (-),Carvedilol, (-)-isomer,Carvedilol, (R)-isomer,Carvedilol, (S)-isomer,Carvedilol, 14C-labeled,Coreg,Coropres,Dilatrend,Eucardic,Kredex,Querto,14C-labeled Carvedilol,BM14190,Carvedilol, 14C labeled
D000319 Adrenergic beta-Antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Adrenergic beta-Antagonist,Adrenergic beta-Receptor Blockader,Adrenergic beta-Receptor Blockaders,beta-Adrenergic Antagonist,beta-Adrenergic Blocker,beta-Adrenergic Blocking Agent,beta-Adrenergic Blocking Agents,beta-Adrenergic Receptor Blockader,beta-Adrenergic Receptor Blockaders,beta-Adrenoceptor Antagonist,beta-Blockers, Adrenergic,beta-Adrenergic Antagonists,beta-Adrenergic Blockers,beta-Adrenoceptor Antagonists,Adrenergic beta Antagonist,Adrenergic beta Antagonists,Adrenergic beta Receptor Blockader,Adrenergic beta Receptor Blockaders,Adrenergic beta-Blockers,Agent, beta-Adrenergic Blocking,Agents, beta-Adrenergic Blocking,Antagonist, beta-Adrenergic,Antagonist, beta-Adrenoceptor,Antagonists, beta-Adrenergic,Antagonists, beta-Adrenoceptor,Blockader, Adrenergic beta-Receptor,Blockader, beta-Adrenergic Receptor,Blockaders, Adrenergic beta-Receptor,Blockaders, beta-Adrenergic Receptor,Blocker, beta-Adrenergic,Blockers, beta-Adrenergic,Blocking Agent, beta-Adrenergic,Blocking Agents, beta-Adrenergic,Receptor Blockader, beta-Adrenergic,Receptor Blockaders, beta-Adrenergic,beta Adrenergic Antagonist,beta Adrenergic Antagonists,beta Adrenergic Blocker,beta Adrenergic Blockers,beta Adrenergic Blocking Agent,beta Adrenergic Blocking Agents,beta Adrenergic Receptor Blockader,beta Adrenergic Receptor Blockaders,beta Adrenoceptor Antagonist,beta Adrenoceptor Antagonists,beta Blockers, Adrenergic,beta-Antagonist, Adrenergic,beta-Antagonists, Adrenergic,beta-Receptor Blockader, Adrenergic,beta-Receptor Blockaders, Adrenergic

Related Publications

Rathindranath Sarkar, and Rudrajit Paul, and Debaditya Roy, and Asim Saha, and Tanmay Jyoti Sau, and Jayati Mondal
Beta-blocker use in systolic heart failure and dilated cardiomyopathy.
January 1997, Journal of clinical pharmacology,
Rathindranath Sarkar, and Rudrajit Paul, and Debaditya Roy, and Asim Saha, and Tanmay Jyoti Sau, and Jayati Mondal
Hypertension: which beta-blocker?
December 1976, Drugs,
Rathindranath Sarkar, and Rudrajit Paul, and Debaditya Roy, and Asim Saha, and Tanmay Jyoti Sau, and Jayati Mondal
Combined therapy with a beta-blocker and a calcium-channel blocker in dilated cardiomyopathy.
September 1998, International journal of cardiology,
Rathindranath Sarkar, and Rudrajit Paul, and Debaditya Roy, and Asim Saha, and Tanmay Jyoti Sau, and Jayati Mondal
Effect of beta-blocker treatment in dilated cardiomyopathy with bradyarrhythmias.
October 1998, Japanese circulation journal,
Rathindranath Sarkar, and Rudrajit Paul, and Debaditya Roy, and Asim Saha, and Tanmay Jyoti Sau, and Jayati Mondal
Which subgroup of patients with dilated cardiomyopathy would benefit from long-term beta-blocker therapy? A histologic viewpoint.
March 1993, Journal of the American College of Cardiology,
Rathindranath Sarkar, and Rudrajit Paul, and Debaditya Roy, and Asim Saha, and Tanmay Jyoti Sau, and Jayati Mondal
Beta-Blocker Use Is Associated With Prevention of Left Ventricular Remodeling in Recovered Dilated Cardiomyopathy.
June 2021, Journal of the American Heart Association,
Rathindranath Sarkar, and Rudrajit Paul, and Debaditya Roy, and Asim Saha, and Tanmay Jyoti Sau, and Jayati Mondal
Effect of beta-blocker therapy in elderly patients with dilated cardiomyopathy.
October 2003, Circulation journal : official journal of the Japanese Circulation Society,
Rathindranath Sarkar, and Rudrajit Paul, and Debaditya Roy, and Asim Saha, and Tanmay Jyoti Sau, and Jayati Mondal
Can beta-blocker therapy be withdrawn from patients with dilated cardiomyopathy?
September 1999, American heart journal,
Rathindranath Sarkar, and Rudrajit Paul, and Debaditya Roy, and Asim Saha, and Tanmay Jyoti Sau, and Jayati Mondal
Seventeen year follow-up of a patient with hypertrophic cardiomyopathy which progressed to dilated cardiomyopathy.
September 1984, Japanese heart journal,
Rathindranath Sarkar, and Rudrajit Paul, and Debaditya Roy, and Asim Saha, and Tanmay Jyoti Sau, and Jayati Mondal
Redefining beta-blocker use in hypertension: selecting the right beta-blocker and the right patient.
January 2017, Journal of the American Society of Hypertension : JASH,
Copied contents to your clipboard!